Showing 7031-7040 of 8790 results for "".
- BTL Cares Scholarship Winners Announcedhttps://practicaldermatology.com/news/btl-cares-scholarship-winners-announced/2461601/BTL Industries, along with professional golfer Michelle Wie West, have announced the winners of the second annual BTL Cares Scholar Draft. The program awards five student-athletes a $15,000 grant for tuition and college fees. The Scholar Draft aims to empow
- Novel Rare Mutation in ABCA12 Gene linked to HIhttps://practicaldermatology.com/news/novel-rare-mutation-in-abca12-gene-linked-to-hi/2461600/A novel rare skin mutation in ABCA12 gene is linked to Harlequin Ichthyosis, according to a new case study published in Frontiers in Pediatrics. Harlequin ichthyosis (HI) is a severe genetic skin disorder characterized by thick white, brown, or dark b
- National Society for Cutaneous Medicine Endorses Use of GEP Testing for Melanomahttps://practicaldermatology.com/news/national-society-for-cutaneous-medicine-endorses-use-of-gep-testing-for-melanoma/2461597/The National Society for Cutaneous Medicine now recommends use of gene expression profile (GEP) testing in the clinical assessment and management of cutaneous melanoma (CM). The report provides usage guidelines and a framework for clinicians to integrate GEP testing into their CM
- Let There Be Light: Lumohs Founder Donates Scalpels to Floating Doctorshttps://practicaldermatology.com/news/let-there-be-light-lumohs-founder-donates-scalpels-to-floating-doctors/2461595/Floating Doctors will be using the Lumohs scalpel when treating underserved patients in areas without electricity or water. The Floating Doctors' volunteer medical teams deploy by boat, packhorse, or on foot to remote underserved areas. The Lumohs is a pate
- Memantine May Improve Trichotillomania, Excoriation Disorderhttps://practicaldermatology.com/news/memantine-may-improve-trichotillomania-excoriation-disorder/2461594/The Alzheimer’s disease memantine effectively reduces symptoms of adults with trichotillomania and skin-picking disorder also known as excoriation disorder, new research shows. Researchers honed in on memantine based on earlier findings that revealed disorganized areas of white ma
- BTL Takes a Stand Against Illegal and Counterfeit Aesthetic Deviceshttps://practicaldermatology.com/news/btl-takes-a-stand-against-illegal-and-counterfeit-aesthetic-devices/2461593/BTL is making inroads in its efforts to safeguard medical providers and consumers from counterfeit devices in the United States through legal action and the seizure of illegally imported devices at the border. BTL has filed court documents stating that defendants use and sell knock
- Study: Lycomato Carotenoid Supplement May Boost Skin Health and Appearancehttps://practicaldermatology.com/news/study-lycomato-carotenoid-supplement-boost-skin-health-and-appearance/2461592/Daily supplementation with Lycomato may improve fine lines, wrinkles, pore appearance brightness/radiance, skin tone evenness, dark spot intensity, smoothness, and firmness after four weeks of use, according to a new study&
- U.S. FDA: Renuvion Cleared to Coagulate and Contract Soft Tissues, Including Subcutaneous Tissuehttps://practicaldermatology.com/news/us-fda-renuvion-cleared-to-coagulate-and-contract-soft-tissues-including-subcutaneous-tissue/2461590/The U.S. Food and Drug Administration (FDA) has cleared the use of the Renuvion APR Handpiece for the delivery of radiofrequency energy and/or helium plasma where coagulation/contraction of soft tissue is needed. (Soft tissue includes subcutaneous tissue.) “We are pleas
- Dyskerin May Signal When SCC Is On The Movehttps://practicaldermatology.com/news/dyskerin-may-signal-when-scc-is-on-the-move/2461585/The protein dyskerin may provide important clues as to how cutaneous squamous cell carcinoma tumors prepare themselves to migrate to the lymph nodes to metastasize other organs, a new study suggests. These cells stop consuming glucose so that they can survive by using LDL chol
- Bristol Myers Squibb Advances Melanoma Drug Candidate Opdivo in US and Europehttps://practicaldermatology.com/news/bristol-myers-squibb-advances-melanoma-drug-candidate-opdivo-in-us-and-europe/2461583/Bristol Myers Squibb announced that the FDA has accepted the supplemental Biologics License Application (BLA) for Opdivo (nivolumab) as monotherapy in the adjuvant setting for the treatment of patients with completely resected stage IIB or IIC melanoma. The company also announced t